- Home
- JNJ vs UBS Comparison
JNJ vs UBS Comparison
Compare JNJ & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JNJ | UBS |
|---|---|---|
| Founded | 1886 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 154.1B |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JNJ | UBS |
|---|---|---|
| Price | $239.06 | $50.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $238.20 | $60.30 |
| AVG Volume (30 Days) | ★ 7.4M | 2.2M |
| Earning Date | 04-14-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.36% | 1.29% |
| EPS Growth | ★ 90.50 | N/A |
| EPS | ★ 2.14 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.63 | $7.40 |
| Revenue Next Year | $7.43 | $2.83 |
| P/E Ratio | $108.08 | ★ $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $150.73 | $32.03 |
| 52 Week High | $251.71 | $51.24 |
Technical Indicators
Market Signals| Indicator | JNJ | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 59.01 | 63.23 |
| Support Level | $233.83 | $46.47 |
| Resistance Level | $244.80 | N/A |
| Average True Range (ATR) | 4.60 | 0.80 |
| MACD | 0.22 | 0.15 |
| Stochastic Oscillator | 87.09 | 80.04 |
Price Performance
Historical ComparisonAbout JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.